Tirzepatide Cuts Type 2 Diabetes Risk by 94% in Adults with Pre-Diabetes and Obesity
INDIANAPOLIS- Eli Lilly and Company announced today positive topline results from the SURMOUNT-1…
FDA Grants Accelerated Approval to Gilead’s Livdelzi for PBC
FOSTER CITY, Calif : Gilead Sciences recently announced that the U.S. Food…